208 related articles for article (PubMed ID: 11459208)
41. Pharmacokinetic study of methotrexate, folinic acid and their serum metabolites in children treated with high-dose methotrexate and leucovorin rescue.
Wolfrom C; Hepp R; Hartmann R; Breithaupt H; Henze G
Eur J Clin Pharmacol; 1990; 39(4):377-83. PubMed ID: 2076721
[TBL] [Abstract][Full Text] [Related]
42. Carboxypeptidase G2 rescue after high-dose methotrexate.
DeAngelis LM; Tong WP; Lin S; Fleisher M; Bertino JR
J Clin Oncol; 1996 Jul; 14(7):2145-9. PubMed ID: 8683248
[TBL] [Abstract][Full Text] [Related]
43. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
[TBL] [Abstract][Full Text] [Related]
44. Clinical use of thymidine as a rescue agent from methotrexate toxicity.
Grem JL; King SA; Sorensen JM; Christian MC
Invest New Drugs; 1991 Aug; 9(3):281-90. PubMed ID: 1838364
[TBL] [Abstract][Full Text] [Related]
45. High-dose methotrexate in acute lymphoblastic leukemia: where is the evidence for its continued use?
Mantadakis E; Cole PD; Kamen BA
Pharmacotherapy; 2005 May; 25(5):748-55. PubMed ID: 15899736
[TBL] [Abstract][Full Text] [Related]
46. High-dose methotrexate in childhood all.
Moe PJ; Holen A
Pediatr Hematol Oncol; 2000 Dec; 17(8):615-22. PubMed ID: 11127393
[TBL] [Abstract][Full Text] [Related]
47. High-dose methotrexate-associated acute renal failure may be an avoidable complication.
Fong CM; Lee AC
Pediatr Hematol Oncol; 2006; 23(1):51-7. PubMed ID: 16326413
[TBL] [Abstract][Full Text] [Related]
48. Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.
Sterba J; Dusek L; Demlova R; Valik D
Clin Chem; 2006 Apr; 52(4):692-700. PubMed ID: 16455868
[TBL] [Abstract][Full Text] [Related]
49. [Successful treatment of high-dose methotrexate-induced oliguric acute renal failure by using a combination of hemodialysis filtration and direct hemoperfusion].
Morozumi I; Inagaki A; Suzuki S; Sato Y; Ogura H; Suga N; Komatsu H; Wakita A; Yamada K
Gan To Kagaku Ryoho; 2015 May; 42(5):609-11. PubMed ID: 25981656
[TBL] [Abstract][Full Text] [Related]
50. Carboxypeptidase G2 rescue in delayed methotrexate elimination in renal failure.
Mohty M; Peyriere H; Guinet C; Hillaire-Buys D; Blayac JP; Rossi JF
Leuk Lymphoma; 2000 Apr; 37(3-4):441-3. PubMed ID: 10752997
[TBL] [Abstract][Full Text] [Related]
51. Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
Heuschkel S; Kretschmann T; Teipel R; von Bonin S; Richter S; Quick S; Alakel N; Röllig C; Balaian E; Kroschinsky F; Knoth H; Bornhäuser M; von Bonin M
Cancer Chemother Pharmacol; 2022 Jan; 89(1):41-48. PubMed ID: 34669022
[TBL] [Abstract][Full Text] [Related]
52. High dose methotrexate infusion with leucovorin rescue for treatment of ectopic pregnancy.
Larson DM; Tipping SJ; Mulligan GM; Johnson KK; Becker J
Wis Med J; 1995 Dec; 94(12):664-7. PubMed ID: 8571615
[TBL] [Abstract][Full Text] [Related]
53. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
[TBL] [Abstract][Full Text] [Related]
54. A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
Schwartz GK; Christman K; Saltz L; Casper E; Quan V; Bertino J; Martin DS; Colofiore J; Kelsen D
Cancer; 1996 Nov; 78(9):1988-95. PubMed ID: 8909321
[TBL] [Abstract][Full Text] [Related]
55. Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
Scott JR; Zhou Y; Cheng C; Ward DA; Swanson HD; Molinelli AR; Stewart CF; Navid F; Jeha S; Relling MV; Crews KR
Pediatr Blood Cancer; 2015 Sep; 62(9):1518-22. PubMed ID: 25631103
[TBL] [Abstract][Full Text] [Related]
56. Renal dysfunction during and after high-dose methotrexate.
Green MR; Chamberlain MC
Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
[TBL] [Abstract][Full Text] [Related]
57. Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
Cohen IJ
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1057-1065. PubMed ID: 28455583
[TBL] [Abstract][Full Text] [Related]
58. Improving the safety of high-dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin.
Vaishnavi K; Bansal D; Trehan A; Jain R; Attri SV
Pediatr Blood Cancer; 2018 Dec; 65(12):e27241. PubMed ID: 29768710
[TBL] [Abstract][Full Text] [Related]
59. Substitution of l-leucovorin for d,l-leucovorin in the rescue from high-dose methotrexate treatment in patients with osteosarcoma.
Jaffe N; Jorgensen K; Robertson R; George M; Letvak L; Barrett G
Anticancer Drugs; 1993 Oct; 4(5):559-64. PubMed ID: 8292813
[TBL] [Abstract][Full Text] [Related]
60. Reduced-dose carboxypeptidase-G2 successfully lowers elevated methotrexate levels in an adult with acute methotrexate-induced renal failure.
Trifilio S; Ma S; Petrich A
Clin Adv Hematol Oncol; 2013 May; 11(5):322-3. PubMed ID: 23880719
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]